User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008).

Primary tabs

Verbeke, Natacha Beguin, Yves Wildiers, Hans Canon, J L Bries, Greet Bosly, André [UCL] Van Belle, Simon

This survey shows that cancer-related anaemia is still frequently observed in cancer patients. Even if in our study ESA were used more frequently than about 10 years ago, still a large amount of anaemic patients who could be treated for anaemia according to EORTC guidelines, were not.

Document type Article de périodique (Journal article)
Access type Accès restreint
Publication date 2012
Language Anglais
Journal information "Supportive Care in Cancer" - Vol. 20, no. 1, p. 23-28 (2012)
Peer reviewed yes
Publisher Springer ((Germany) Heidelberg)
issn 0941-4355
e-issn 1433-7339
Publication status Publié
Affiliations UCL - SSS/IREC/MONT - Pôle Mont Godinne
UCL - (MGD) Service d'hématologie
MESH Subject Aged ; Middle Aged ; Multivariate Analysis ; Neoplasms ; Practice Guidelines as Topic ; Prevalence ; Severity of Illness Index ; Anemia ; Belgium ; Data Collection ; Female ; Hemoglobins ; Hospitalization ; Humans ; Male
Links
  1. Ludwig Heinz, Van Belle Simon, Barrett-Lee Peter, Birgegård Gunnar, Bokemeyer Carsten, Gascón Pere, Kosmidis Paris, Krzakowski Maciej, Nortier Johan, Olmi Patrizia, Schneider Maurice, Schrijvers Dirk, The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients, 10.1016/j.ejca.2004.06.019
  2. Caro J. Jaime, Salas Maribel, Ward Alexandra, Goss Glenwood, Anemia as an independent prognostic factor for survival in patients with cancer : A systematic, quantitative review, 10.1002/1097-0142(20010615)91:12<2214::aid-cncr1251>3.0.co;2-p
  3. Aapro M. S., Link H., September 2007 Update on EORTC Guidelines and Anemia Management with Erythropoiesis-Stimulating Agents, 10.1634/theoncologist.13-s3-33
  4. Kitano Toshiyuki, Tada Harue, Nishimura Tsutomu, Teramukai Satoshi, Kanai Masashi, Nishimura Takafumi, Misawa Akiko, Yoshikawa Kiyotsugu, Yasuda Hiroyasu, Ishiguro Hiroshi, Matsumoto Shigemi, Yanagihara Kazuhiro, Fukushima Masanori, Prevalence and Incidence of Anemia in Japanese Cancer Patients Receiving Outpatient Chemotherapy, 10.1532/ijh97.07040
  5. Tas Faruk, Eralp Yesim, Basaran Mert, Sakar Burak, Alici Suleyman, Argon Andac, Bulutlar Gulistan, Camlica Hakan, Aydiner Adnan, Topuz Erkan, Anemia in Oncology Practice : Relation to Diseases and Their Therapies, 10.1097/00000421-200208000-00011
  6. Seshadri T, Prince HM, Bell DR et al (2005) The Australian Cancer Anaemia Survey: a snapshot of anaemia in adult patients with cancer. Med J Aust 182:453–457
  7. Demetri GD, Kris M, Wade J et al (1998) Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. J Clin Oncol 16:3412–3425
  8. Pelegrí A., Impact of erythropoietin treatment on the quality of life of oncologic patients, 10.1007/s12094-007-0117-1
  9. Glaspy J, Bukowski R, Steinberg D et al (1997) Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. J Clin Oncol 15:1218–1234
  10. Bohlius J., Wilson J., Seidenfeld J., Piper M., Schwarzer G., Sandercock J., Trelle S., Weingart O., Bayliss S., Djulbegovic B., Bennett C. L., Langensiepen S., Hyde C., Engert A., Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients, 10.1093/jnci/djj189
  11. Bennett Charles L., Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated Anemia, 10.1001/jama.299.8.914
  12. Henke Michael, Mattern Dominik, Pepe Margaret, Bézay Christina, Weissenberger Christian, Werner Martin, Pajonk Frank, Do Erythropoietin Receptors on Cancer Cells Explain Unexpected Clinical Findings?, 10.1200/jco.2006.06.2737
  13. Bohlius Julia, Schmidlin Kurt, Brillant Corinne, Schwarzer Guido, Trelle Sven, Seidenfeld Jerome, Zwahlen Marcel, Clarke Michael, Weingart Olaf, Kluge Sabine, Piper Margaret, Rades Dirk, Steensma David P, Djulbegovic Benjamin, Fey Martin F, Ray-Coquard Isabelle, Machtay Mitchell, Moebus Volker, Thomas Gillian, Untch Michael, Schumacher Martin, Egger Matthias, Engert Andreas, Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials, 10.1016/s0140-6736(09)60502-x
  14. Ludwig Heinz, Aapro Matti, Bokemeyer Carsten, MacDonald Karen, Soubeyran Pierre, Turner Matthew, Albrecht Tara, Abraham Ivo, Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: Findings from the Anaemia Cancer Treatment (ACT) study, 10.1016/j.ejca.2009.02.003
Bibliographic reference Verbeke, Natacha ; Beguin, Yves ; Wildiers, Hans ; Canon, J L ; Bries, Greet ; et. al. High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008).. In: Supportive Care in Cancer, Vol. 20, no. 1, p. 23-28 (2012)
Permanent URL http://hdl.handle.net/2078.1/124226